6/23付の米国FDAによるCOVID-19絡みガイダンス等の発出について、筆者のお好みでお伝えします。
関係者および興味のある方は、下記URLsのNews Release等をご参照ください。
l6/23付Updated「Coronavirus Disease 2019 (COVID-19)」
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19
l6/23付Updated「Coronavirus (COVID-19) Update: Daily Roundup June 23, 2020」
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-june-23-2020
l6/223付Updated「Emergency Use Authorizations」
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
l6/23付Updated「FAQs on Diagnostic Testing for SARS-CoV-2」
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2
l6/23付FDA Voices「FDA Maintains the Pace of Meeting Its Goals on Applications for Medical Products During the Pandemic」
https://www.fda.gov/news-events/fda-voices/fda-maintains-pace-meeting-its-goals-applications-medical-products-during-pandemic
関係者および興味のある方は、下記URLsのNews Release等をご参照ください。
l6/23付Updated「Coronavirus Disease 2019 (COVID-19)」
https://www.fda.gov/emergency-
l6/23付Updated「Coronavirus (COVID-19) Update: Daily Roundup June 23, 2020」
https://www.fda.gov/news-
l6/223付Updated「Emergency Use Authorizations」
https://www.fda.gov/medical-
l6/23付Updated「FAQs on Diagnostic Testing for SARS-CoV-2」
https://www.fda.gov/medical-
l6/23付FDA Voices「FDA Maintains the Pace of Meeting Its Goals on Applications for Medical Products During the Pandemic」
https://www.fda.gov/news-
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント